TM
TWST icon

Torren Management’s Twist Bioscience TWST Stock Holding History

Torren Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.2K Hold
70
– – ﹤0.01% 257
2026
Q1 		$3.33K Sell
70
-147
-68% -$6.59K ﹤0.01% 413
2025
Q4 		$6.88K Buy
+217
New +$6.77K ﹤0.01% 855

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Torren Management's TWST Position: Q2 2026 in Review

Torren Management held its Twist Bioscience (TWST) position steady in Q2 2026 at 70 shares worth $7.2K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Torren Management first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Torren Management held 70 shares of Twist Bioscience worth $7.2K as of Q2 2026.
  • Torren Management left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #257 holding.
  • Torren Management first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 123 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.